Answers are grounded in this paper and cite their sources.
A number of thiosemicarbazones of 2-acetyl-imidazo[4,5-b]pyridine were prepared in order to investigate their in vitro antineoplastic activities. Three compounds: (i) 2-acetylimidazo[4,5-b]pyridin-4-sec-butyl-3-thiosemicarbazone [(A7), NSC674098], (ii) 2-acetylimidazo[4,5-b]pyridin-4-tert-butyl-3-thiosemi-carbazone [(A9), NSC674099], (iii) 2-acetylimidazo[4,5-b]pyridin-4-cyclohexyl-3-thiosemicarbozone [(A11), NSC674101] showed remarkable activity against some of the cell lines tested. The Biological Evaluation Committee of N.C.I. determined that further secondary testing should be carried out (these compounds were tested against prostate cancer).
No takes yet. Share an insight, caveat, or question.
Mylonas et al. (2005) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: